Israel Englander’s Oruka Therapeutics ORKA Stock Holding History

Israel Englander’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.13M	Buy	+32,866	New	+$2.19M	﹤0.01%	3425
2026 Q1	–	Sell	-58,723	Closed	-$1.78M	–	6522
2025 Q4	$1.78M	Buy	+58,723	New	+$1.64M	﹤0.01%	4047
2025 Q3	–	Sell	-12,326	Closed	-$138K	–	6557
2025 Q2	$138K	Sell	12,326 -41,800	-77%	-$436K	﹤0.01%	5465
2025 Q1	$555K	Buy	54,126 +23,821	+79%	+$297K	﹤0.01%	4742
2024 Q4	$588K	Buy	+30,305	New	+$739K	﹤0.01%	4622
2022 Q4	–	Sell	-3,105	Closed	-$77K	–	7142
2022 Q3	$77K	Sell	3,105 -1,843	-37%	-$52.1K	﹤0.01%	6054
2022 Q2	$148K	Buy	4,948 +3,996	+420%	+$113K	﹤0.01%	5776
2022 Q1	$26K	Sell	952 -1,419	-60%	-$35.2K	﹤0.01%	6579
2021 Q4	$61K	Buy	2,371 +1,048	+79%	+$31.6K	﹤0.01%	6424
2021 Q3	$47K	Buy	+1,323	New	+$48.9K	﹤0.01%	6585
2018 Q2	–	Sell	-52	Closed	-$6K	–	4248
2018 Q1	$6K	Buy	+52	New	+$14K	﹤0.01%	3579
2016 Q4	–	Sell	-49	Closed	-$30K	–	3811
2016 Q3	$30K	Buy	+49	New	+$31.6K	﹤0.01%	3205

Other funds holding ORKA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Israel Englander's ORKA Position: Q2 2026 in Review

Israel Englander opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 32,866 shares worth $3.13M. The stake represents ﹤0.01% of the portfolio and ranks #3425 among its holdings. This is a return to the name: Israel Englander previously reported a position in ORKA as recently as Q4 2025.

Israel Englander first reported a position in ORKA in Q3 2016 and has held it in 12 quarters since. 254 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

Israel Englander held 32,866 shares of Oruka Therapeutics worth $3.13M as of Q2 2026.
Oruka Therapeutics was a new Israel Englander position in Q2 2026.
Oruka Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3425 holding.
Israel Englander first reported a position in Oruka Therapeutics in Q3 2016 and has held it in 12 quarters since.
254 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.